Pharma Journalist - Page 51 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Jazz Pharmaceuticals Signs Exclusive Licensing Deal with Saniona for SAN2355 Development

FDA Grants Orphan Drug Designation to Crinetics’ Atumelnant for Congenital Adrenal Hyperplasia

Boehringer Ingelheim, AnGes Ink Manufacturing Deal for HGF Gene Therapy

PTC Therapeutics Gets FDA Complete Response Letter for Vatiquinone NDA

Santen, RemeGen Ink Licensing Deal for Dual-Target Eye Drug RC28-E

Madrigal’s Rezdiffra Approved in EU for MASH Treatment

European Commission Approves OGSIVEO for Adult Desmoid Tumors

FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGFR-Mutant Lung Cancer

Boehringer Ingelheim, Palatin Technologies Partner to Develop Melanocortin Receptor Therapy for Retinal Diseases

Precigen’s PAPZIMEOS Gets Full FDA Approval for Recurrent Respiratory Papillomatosis